Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 39.52115.92-94.85-1,170.52-

What is the latest Core EBITDA Growth ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Growth ratio of BROOKS LABORATORIES is 39.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202539.52
Mar2024115.92
Mar2023-94.85
Mar2022-1,170.52
Mar2021-

How is Core EBITDA Growth of BROOKS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 39.52
-65.91
Mar2024 115.92
Positive
Mar2023 -94.85
Negative
Mar2022 -1170.52
0
Mar2021 0 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Growth ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹173.5 Cr -8.4% -18.8% -61.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹480,047.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹208,141.0 Cr 8.2% 19.8% 17.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,264.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,430.0 Cr 3.9% 0.6% 0% Stock Analytics
DR REDDYS LABORATORIES ₹95,516.1 Cr -0.7% -14.6% -8.4% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-8.4%

-18.8%

-61.7%

SENSEX

2%

1.9%

-5.2%


You may also like the below Video Courses